000			02028 a2200541 4500
005			20250515061138.0
264		0	_c20070711
008			200707s 0 0 eng d
022			_a0022-3751
024	7		_a10.1113/jphysiol.2006.127423 _2doi
040			_aNLM _beng _cNLM
100	1		_aMortensen, Stefan P
245	0	0	_aInhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg. _h[electronic resource]
260			_bThe Journal of physiology _cJun 2007
300			_a853-61 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine Triphosphate _xblood
650	0	4	_aAdult
650	0	4	_aBiological Factors _xmetabolism
650	0	4	_aBlood Flow Velocity
650	0	4	_aCardiac Output
650	0	4	_aCyclooxygenase Inhibitors _xpharmacology
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aEnergy Metabolism _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aExercise
650	0	4	_aHeart Rate
650	0	4	_aHumans
650	0	4	_aHyperemia _xmetabolism
650	0	4	_aIndomethacin _xpharmacology
650	0	4	_aLeg
650	0	4	_aMale
650	0	4	_aMuscle, Skeletal _xblood supply
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aOxygen Consumption
650	0	4	_aPotassium Channel Blockers _xpharmacology
650	0	4	_aProstaglandins _xmetabolism
650	0	4	_aRegional Blood Flow
650	0	4	_aTetraethylammonium _xpharmacology
650	0	4	_aomega-N-Methylarginine _xpharmacology
700	1		_aGonzález-Alonso, José
700	1		_aDamsgaard, Rasmus
700	1		_aSaltin, Bengt
700	1		_aHellsten, Ylva
773	0		_tThe Journal of physiology _gvol. 581 _gno. Pt 2 _gp. 853-61
856	4	0	_uhttps://doi.org/10.1113/jphysiol.2006.127423 _zAvailable from publisher's website
999			_c16903668 _d16903668